| Health / Medical Topics |
Atracurium Besylate
A synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects. Not dependent on kidney function for elimination, it provides clinical advantages over other non-depolarizing, neuromuscular blocking agents. (NCI Thesaurus)
YOU MAY ALSO LIKE
A regimen consisting of tretinoin (all-trans retinoic acid or ATRA) and daunorubicin used as an induction treatment for acute promyelocytic leukemia…
A nutrient that the body needs in small amounts to function and stay healthy. ATRA is made in the body from vitamin…
ATR-interacting protein (791 aa, ~86 kDa) is encoded by the human ATRIP gene. This protein is involved in signaling during the DNA…
An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101 selectively kills adrenal and…
Human ATR wild-type allele is located within 3q22-q24 and is approximately 130 kb in length. This allele, which encodes serine/threonine-protein kinase ATR…
An orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, ATR kinase…
